The problem is how do you price fairly when hitting on a therapy that makes it to production is like winning the lottery because it's so rare. Then you get a m

The problem is how do you price fairly when hitting on a therapy that makes it to production is like winning the lottery because it's so rare. Then you get a monopoly with a patent and start thinking about shareholders and it's not like there's any sort of valid competition in breakthrough medicine. The whole industry is screwed up.